Biosimilar Antibodies
Research-grade antibodies based on approved therapeutic antibodies — including checkpoint inhibitors, anti-TNF and oncology mAbs — for assay development, binding studies and in vitro research.
Browse by
An antibody produced from the published sequence of an approved therapeutic, for research use only. It lets labs use a therapeutic-equivalent binder as an assay reagent, control or reference.
Validated applications, species reactivity and recommended dilutions are listed on each product page.
Yes — contact our team with your target, format and quantity.